Mechanisms of Resolution of Inflammation A Focus on Cardiovascular Disease

被引:132
|
作者
Maskrey, Benjamin H. [1 ]
Megson, Ian L. [2 ]
Whitfield, Phillip D.
Rossi, Adriano G. [3 ]
机构
[1] Ctr Hlth Sci, Highland Diabet Inst, UHI Dept Diabet & Cardiovasc Sci, Lipid Res Facil, Inverness IV2 3JH, Scotland
[2] Ctr Hlth Sci, Highland Diabet Inst, Free Rad Res Facil, Inverness IV2 3JH, Scotland
[3] Univ Edinburgh, Sch Med, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
基金
英国医学研究理事会;
关键词
atherosclerosis; eicosanoids; lipids; NO; resolution of inflammation; NITRIC-OXIDE; FATTY-ACIDS; ANTIINFLAMMATORY ACTIONS; MACROPHAGE PHAGOCYTOSIS; APOPTOTIC NEUTROPHILS; 15-EPI-LIPOXIN A(4); LIPID MEDIATORS; R-ROSCOVITINE; ASPIRIN; ATHEROSCLEROSIS;
D O I
10.1161/ATVBAHA.110.213850
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The inflammatory response is an integral part of the innate immune mechanism that is triggered in response to a real or perceived threat to tissue homeostasis, with a primary aim of neutralizing infectious agents and initiating repair to damaged tissue. By design, inflammation is a finite process that resolves as soon as the threat of infection abates and sufficient repair to the tissue is complete. Resolution of inflammation involves apoptosis and subsequent clearance of activated inflammatory cells - a tightly regulated event. Chronic inflammation is a characteristic feature in virtually all inflammatory diseases, including atherosclerosis, and it is becoming increasingly clear that derangement of the processes usually involved in resolution of inflammation is an underlying feature of chronic inflammatory conditions. This review will draw on evidence from a range of diseases in which dysregulated inflammation is important, with particular emphasis on cardiovascular disease. (Arterioscler Thromb Vasc Biol. 2011;31:1001-1006.)
引用
收藏
页码:1001 / 1006
页数:6
相关论文
共 50 条
  • [1] Inflammation and cardiovascular disease mechanisms
    Libby, P
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (02): : 456S - 460S
  • [2] Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease
    Zhang, Jishou
    Ding, Wen
    Zhao, Mengmeng
    Liu, Jianfang
    Xu, Yao
    Wan, Jun
    Wang, Menglong
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (23) : 5151 - 5171
  • [3] Inflammation and cardiovascular disease: From mechanisms to therapeutics
    Alfaddagh, Abdulhamied
    Martin, Seth S.
    Leucker, Thorsten M.
    Michos, Erin D.
    Blaha, Michael J.
    Lowenstein, Charles J.
    Jones, Steven R.
    Toth, Peter P.
    [J]. AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 4
  • [4] Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease
    Pirault, John
    Back, Magnus
    [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [5] New Approaches for the Prevention and Treatment of Cardiovascular Disease: Focus on Lipoproteins and Inflammation
    Hussain, Aliza
    Ballantyne, Christie M.
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 72, 2021, 2021, 72 : 431 - 446
  • [6] Adipokines and Inflammation: Focus on Cardiovascular Diseases
    Feijoo-Bandin, Sandra
    Aragon-Herrera, Alana
    Morana-Fernandez, Sandra
    Anido-Varela, Laura
    Tarazon, Estefania
    Rosello-Lleti, Esther
    Portoles, Manuel
    Moscoso, Isabel
    Gualillo, Oreste
    Gonzalez-Juanatey, Jose Ramon
    Lago, Francisca
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 34
  • [8] Focus on cardiovascular disease
    Noel, Alain
    [J]. ACTUALITES PHARMACEUTIQUES, 2012, 51 (519): : 7 - 7
  • [9] Focus Issue: Understanding Mechanisms of Inflammation
    Foley, John F.
    [J]. SCIENCE SIGNALING, 2013, 6 (258)
  • [10] Editorial: Inflammation and cardiovascular disease: Vascular responses, mechanisms and therapeutic implications
    Villalba, Nuria
    Wellman, George C.
    [J]. FRONTIERS IN PHYSIOLOGY, 2022, 13